Trials / Completed
CompletedNCT01426386
A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 265 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 37 Years
- Healthy volunteers
- Not accepted
Summary
This trial investigates the effects of several doses of FE 999049 in women undergoing IVF/ICSI (in-vitro fertilisation/intracytoplasmic sperm injection) treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FE 999049 | |
| DRUG | Gonal - F |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-04-01
- Completion
- 2013-03-01
- First posted
- 2011-08-31
- Last updated
- 2020-11-17
- Results posted
- 2018-08-03
Locations
8 sites across 4 countries: Belgium, Czechia, Denmark, Spain
Source: ClinicalTrials.gov record NCT01426386. Inclusion in this directory is not an endorsement.